Glucotrack (GCTK) revenue and earnings history
Glucotrack's annual figures for 17 fiscal years, as filed with the SEC.
Over 5 years, from fiscal 2014 to fiscal 2019, revenue grew at a compound rate of +28.3% a year.
Revenue and net income, 17 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | — | −$16.1M | −$19.4M | −$15.2M | $96K | −$15.3M | $211K | — | — | $7.38M | — | 10-K |
| 2024ended Dec 31, 2024 | — |
The latest quarter, insider trades and fund moves: Glucotrack (GCTK) on OQRO.
Common questions
How fast has Glucotrack's revenue grown?
From $60K in fiscal 2014 to $208K in fiscal 2019: a compound annual growth rate of +28.3% over 5 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Glucotrack been profitable?
It reported a net loss in 11 of the years shown (2012, 2013, 2015, 2016, 2018, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was $10.3M in fiscal 2017.
What was Glucotrack's free cash flow in fiscal 2025?
−$15.3M: operating cash flow of −$15.2M minus capital expenditure of $96K. OQRO calculates free cash flow this way from the two filed lines.
Where these figures come from
The SEC’s companyfacts data: every figure Glucotrack tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
